Biomarkers and Sensing for Cardiovascular Diseases

Despite decades of efforts, cardiovascular diseases (CVDs) and related heart failure continue
to be the leading cause of morbidity and mortality globally and have a progressively increasing prevalence. It is increasingly recognized that CVDs must be detected early in order for medical intervention to be effective.

Achieving the goal of early detection of CVD requires specific prognostic biomarkers for early CVD detection and sensing technologies capable of sensitively detecting the biomarkers in various biological samples. Therefore, discovering novel biomarkers and developing unique sensor technology platforms and devices for biomarker detections play a central role in early identification and medical intervention of CVDs and potential heart failure. Continue reading >